Theratechnologies (TSE:TH) Stock Passes Above Fifty Day Moving Average – Here’s What Happened

Theratechnologies Inc. (TSE:THGet Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$1.78 and traded as high as C$2.16. Theratechnologies shares last traded at C$2.15, with a volume of 28,012 shares changing hands.

Theratechnologies Stock Performance

The company has a market cap of C$98.86 million, a PE ratio of -11.94, a P/E/G ratio of -8.50 and a beta of 1.73. The company has a debt-to-equity ratio of 562.07, a quick ratio of 0.64 and a current ratio of 1.10. The stock’s 50-day simple moving average is C$1.78 and its 200 day simple moving average is C$1.80.

Theratechnologies (TSE:THGet Free Report) last posted its quarterly earnings results on Thursday, October 10th. The company reported C$0.09 earnings per share (EPS) for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The firm had revenue of C$30.96 million during the quarter. As a group, equities analysts anticipate that Theratechnologies Inc. will post 0.0298643 EPS for the current year.

Theratechnologies Company Profile

(Get Free Report)

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.

Recommended Stories

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.